Work

Ketamine in neuropsychiatric disorders: an update

Year: 2023

Type: review

Source: Neuropsychopharmacology

DOI: 10.1038/s41386-023-01632-1

Authors: Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, Ioline D. Henter, Carlos A. Zarate

Institutions: National Institutes of Health, National Institute of Mental Health, Jazz Pharmaceuticals (United States), Medical University of Vienna

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health

Awards: G4088721472, Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect

OpenAlex ID: W4381334012

FWCI: 3.376

Cites: 218

Cited by: 114

Related to: 10